Literature DB >> 10551752

Ventral hernia synthetic mesh repair infected by Mycobacterium fortuitum.

M R Matthews1, D M Caruso, R B Tsujimura, J D Smilack, B A Pockaj, J M Malone.   

Abstract

We report the occurrence of a refractory infection caused by the "rapidly growing" nontuberculous mycobacterium, Mycobacterium fortuitum, after incisional hernia repair using synthetic mesh. The patient had previously undergone three herniorrhaphies incorporating polypropylene mesh. Multiple surgical debridements were required, along with complete removal of all the mesh, to eradicate the infection. Prolonged antimicrobial therapy with sulfamethoxazole, an agent active against the patient's isolate, was also used. Although this atypical mycobacterium has been reported to cause a variety of infections, including many types of periprosthetic infections, this case represents successful treatment of M. fortuitum infecting abdominal wall mesh.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551752

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  4 in total

1.  The analysis of infection after polypropylene mesh repair of abdominal wall hernia.

Authors:  Arnolds Jezupovs; Arnolds Jezupors; Māris Mihelsons
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

2.  Reconstruction of an infected recurrent ventral hernia after a mesh repair using a pedicled tensor fascia lata flap: report of two cases.

Authors:  Shinya Hayami; Tsukasa Hotta; Katsunari Takifuji; Makoto Iwahashi; Yasuyuki Mitani; Hiroki Yamaue
Journal:  Surg Today       Date:  2009-09-24       Impact factor: 2.549

3.  Hernia repair mesh-associated Mycobacterium goodii infection.

Authors:  Muhammad R Sohail; Jerry D Smilack
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

4.  Biodegradable rifampicin-releasing coating of surgical meshes for the prevention of bacterial infections.

Authors:  Jochen Reinbold; Teresa Hierlemann; Lukas Urich; Ann-Kristin Uhde; Ingrid Müller; Tobias Weindl; Ulrich Vogel; Christian Schlensak; Hans Peter Wendel; Stefanie Krajewski
Journal:  Drug Des Devel Ther       Date:  2017-09-18       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.